ACTRN12612000245897招募中4 期
A randomized parallel group study of glucocorticoids influence on sugammadex efficacy in patients anesthetized for elective surgery
niversity Medical Center Ljubljana0 个研究点目标入组 60 人开始时间: 2012年2月28日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •Patients anesthetized for elective surgery for which they need to be intubated and fully relaxed throughout the procedure, ASA I-III.
排除标准
- •Lack of consent, patients with neuromuscular disease, with anticipated difficult intubation, kidney failure, personal or family history of malignant hyperthermia, allergy to any anesthetics used, pregnant or nursing women, women taking oral contraceptives, patients receiving drugs that could interfere with sugammadex.
研究者
相似试验
已完成
不适用
A double-blind, controlled study of corticosteroid injection in plantar fasciitisISRCTN36539116Arthritis Research Campaign (ARC) (UK)
进行中（未招募）
1 期
A randomised, 2-arm, parallel group study assessing safety and efficacy of titrated transdermal buprenorphine in patients with moderate to severe chronic non malignant pain - Titrated transdermal buprenorphine patch in moderate to severe chronic paiEUCTR2005-005365-11-HUGrünenthal GmbH246
进行中（未招募）
不适用
A randomised, 2-arm, parallel group study assessing efficacy and tolerability of titrated transdermal buprenorphine in patients with moderate to severe chronic non malignant pain - Titrated transdermal buprenorphine patch in moderate to severe chronic paiEUCTR2005-005365-11-ATGrünenthal GmbH246
进行中（未招募）
1 期
A randomised, 2-arm, parallel group study assessing efficacy and tolerability of titrated transdermal buprenorphine in patients with moderate to severe chronic non malignant pain - Titrated transdermal buprenorphine patch in moderate to severe chronic paiModerate to severe chronic painEUCTR2005-005365-11-GBGrünenthal GmbH
已完成
不适用
Olanzapine (ZYPREXA) versus Haloperidol (Novo-Peridol) for the relief of Nausea and Vomiting (N&V) in patients with advanced cancerISRCTN58624349niversity of British Columbia (Canada)80